Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 734 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Pleiotropic effects of incretins

Gupta Vishal

Year : 2012| Volume: 16| Issue : 7 | Page no: 47-56

   This article has been cited by
1 The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet
Rashmi Pathak,Avinash Kumar,Henry A. Palfrey,Laura A. Forney,Kirsten P. Stone,Narayan R. Raju,Thomas W. Gettys,Subramanyam N. Murthy
Inflammation Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice
Ana Babic Perhoc,Jelena Osmanovic Barilar,Ana Knezovic,Vladimir Farkas,Robert Bagaric,Alfred Svarc,Edna Grünblatt,Peter Riederer,Melita Salkovic-Petrisic
Neuropharmacology. 2019; 148: 50
[Pubmed]  [Google Scholar] [DOI]
3 Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review
Weimin Ni,Xiangæen Shi
World Neurosurgery. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Silvano Paternoster,Marco Falasca
Frontiers in Endocrinology. 2018; 9
[Pubmed]  [Google Scholar] [DOI]
5 Glucagon-like peptide-1 analogue liraglutide facilitates wound healing by activating PI3K/Akt pathway in keratinocytes
Konosuke Nagae,Hiroshi Uchi,Saori Morino-Koga,Yuka Tanaka,Mari Oda,Masataka Furue
Diabetes Research and Clinical Practice. 2018;
[Pubmed]  [Google Scholar] [DOI]
6 Hypothalamic obesity after craniopharyngioma surgery: Treatment with a long acting glucagon like peptide 1 derivated
Inés Castro-Dufourny,Rodrigo Carrasco,José María Pascual
Endocrinología, Diabetes y Nutrición (English ed.). 2017;
[Pubmed]  [Google Scholar] [DOI]
7 Obesidad hipotalámica tras intervención quirúrgica de un craneofaringioma: tratamiento con un análogo del péptido similar al glucagón tipo 1
Inés Castro-Dufourny,Rodrigo Carrasco,José María Pascual
Endocrinología, Diabetes y Nutrición. 2017;
[Pubmed]  [Google Scholar] [DOI]
V. K. Bayrasheva,A. Y. Babenko,A. A. Bayramov,S. G. Chefu,I. S. Shatalov,I. Y. Pchelin,A. N. Arefieva,E. N. Grineva
Medical Council. 2017; (3): 8
[Pubmed]  [Google Scholar] [DOI]
9 Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving ß-catenin
Xuelun Wu,Shilun Li,Peng Xue,Yukun Li
Experimental Cell Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
10 The regulation of function, growth and survival of GLP-1-producing L-cells
Rune E. Kuhre,Jens J. Holst,Camilla Kappe
Clinical Science. 2016; 130(2): 79
[Pubmed]  [Google Scholar] [DOI]
11 BMI and BMD: The Potential Interplay between Obesity and Bone Fragility
Andrea Palermo,Dario Tuccinardi,Giuseppe Defeudis,Mikiko Watanabe,Luca D’Onofrio,Angelo Lauria Pantano,Nicola Napoli,Paolo Pozzilli,Silvia Manfrini
International Journal of Environmental Research and Public Health. 2016; 13(6): 544
[Pubmed]  [Google Scholar] [DOI]
12 Exenatide and Sitagliptin Decrease Interleukin 1ß, Matrix Metalloproteinase 9, and Nitric Oxide Synthase 2 Gene Expression But Does Not Reduce Alveolar Bone Loss in Rats With Periodontitis
Renata M. Moraes,Gabriela M. G. Lima,Felipe E. Oliveira,Ana Carolina V. Brito,Rodrigo C. Pereira,Luciane D. Oliveira,Patrícia P. Barros,Gilson C. N. Franco,Ana Lia Anbinder
Journal of Periodontology. 2015; 86(11): 1287
[Pubmed]  [Google Scholar] [DOI]
13 GLP-1R activation for the treatment of stroke: Updating and future perspectives
Vladimer Darsalia,David Nathanson,Thomas Nyström,Thomas Klein,Åke Sjöholm,Cesare Patrone
Reviews in Endocrine and Metabolic Disorders. 2014;
[Pubmed]  [Google Scholar] [DOI]
14 Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
Francisco Saraiva,Andrei C Sposito
Cardiovascular Diabetology. 2014; 13(1): 142
[Pubmed]  [Google Scholar] [DOI]


Read this article